These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17191861)

  • 1. Associating hyaluronan derivatives: a novel horizon in viscosupplementation of osteoarthritic joints.
    Soltés L; Mendichi R; Kogan G; Mach M
    Chem Biodivers; 2004 Mar; 1(3):468-72. PubMed ID: 17191861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of two host-guest associating hyaluronan derivatives.
    Soltés L; Mendichi R
    Biomed Chromatogr; 2003 Sep; 17(6):376-84. PubMed ID: 13680848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viscosupplementation for treatment of osteoarthritis: from initial discovery to current status and results.
    Balazs EA
    Surg Technol Int; 2004; 12():278-89. PubMed ID: 15455338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of radius of gyration and intrinsic viscosity molar mass dependence and stiffness of hyaluronan.
    Mendichi R; Soltés L; Giacometti Schieroni A
    Biomacromolecules; 2003; 4(6):1805-10. PubMed ID: 14606912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular weight of therapeutic hyaluronan (sodium hyaluronate): how significant is it?
    Aviad AD; Houpt JB
    J Rheumatol; 1994 Feb; 21(2):297-301. PubMed ID: 8182640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel hyaluronic acid-methotrexate conjugates for osteoarthritis treatment.
    Homma A; Sato H; Okamachi A; Emura T; Ishizawa T; Kato T; Matsuura T; Sato S; Tamura T; Higuchi Y; Watanabe T; Kitamura H; Asanuma K; Yamazaki T; Ikemi M; Kitagawa H; Morikawa T; Ikeya H; Maeda K; Takahashi K; Nohmi K; Izutani N; Kanda M; Suzuki R
    Bioorg Med Chem; 2009 Jul; 17(13):4647-56. PubMed ID: 19457673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hyaluronan-protein complexes at low ionic strength: how the hyaluronidase activity is controlled by the bovine serum albumin.
    Lenormand H; Tranchepain F; Deschrevel B; Vincent JC
    Matrix Biol; 2009 Jul; 28(6):365-72. PubMed ID: 19394422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viscosupplementation: a new concept in the treatment of osteoarthritis.
    Balazs EA; Denlinger JL
    J Rheumatol Suppl; 1993 Aug; 39():3-9. PubMed ID: 8410881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-articular hyaluronan therapy.
    Marshall KW
    Foot Ankle Clin; 2003 Jun; 8(2):221-32, viii. PubMed ID: 12911237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel biocompatible hyaluronic acid-chitosan hybrid hydrogel for osteoarthrosis therapy.
    Kaderli S; Boulocher C; Pillet E; Watrelot-Virieux D; Rougemont AL; Roger T; Viguier E; Gurny R; Scapozza L; Jordan O
    Int J Pharm; 2015 Apr; 483(1-2):158-68. PubMed ID: 25666331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viscosupplementation with high molecular weight native hyaluronan. Focus on a 1500-2000 KDa fraction (Hyalubrix®).
    Guidolin D; Franceschi F
    Eur Rev Med Pharmacol Sci; 2014; 18(21):3326-38. PubMed ID: 25487947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH effects on the hyaluronan hydrolysis catalysed by hyaluronidase in the presence of proteins: Part I. Dual aspect of the pH-dependence.
    Lenormand H; Deschrevel B; Vincent JC
    Matrix Biol; 2010 May; 29(4):330-7. PubMed ID: 20043995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hyaluronic acid molecular weight on the morphology of quantum dot-hyaluronic acid conjugates.
    Kim J; Park K; Hahn SK
    Int J Biol Macromol; 2008 Jan; 42(1):41-5. PubMed ID: 17936350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current thinking on viscosupplementation in osteoarthritis.
    Jay GD
    Med Health R I; 2004 Jul; 87(7):213-5. PubMed ID: 15354797
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of different molecular weight hyaluronan products on the expression of urokinase plasminogen activator and inhibitor and gelatinases during the early stage of osteoarthritis.
    Hsieh YS; Yang SF; Lue KH; Chu SC; Lu KH
    J Orthop Res; 2008 Apr; 26(4):475-84. PubMed ID: 17975844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative rheological behavior of hyaluronan from bacterial and animal sources with cross-linked hyaluronan (hylan) in aqueous solution.
    Milas M; Rinaudo M; Roure I; Al-Assaf S; Phillips GO; Williams PA
    Biopolymers; 2001 Oct; 59(4):191-204. PubMed ID: 11473346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrostatic interactions between hyaluronan and proteins at pH 4: how do they modulate hyaluronidase activity.
    Lenormand H; Deschrevel B; Tranchepain F; Vincent JC
    Biopolymers; 2008 Dec; 89(12):1088-103. PubMed ID: 18677769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and partial characterization of hydrogels obtained via glutaraldehyde crosslinking of acetylated chitosan and of hyaluronan derivatives.
    Crescenzi V; Francescangeli A; Taglienti A; Capitani D; Mannina L
    Biomacromolecules; 2003; 4(4):1045-54. PubMed ID: 12857091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of diclofenac etalhyaluronate (SI-613) on the production of high molecular weight sodium hyaluronate in human synoviocytes.
    Kisukeda T; Onaya J; Yoshioka K
    BMC Musculoskelet Disord; 2019 May; 20(1):201. PubMed ID: 31077160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronan-phospholipid interactions.
    Pasquali-Ronchetti I; Quaglino D; Mori G; Bacchelli B; Ghosh P
    J Struct Biol; 1997 Oct; 120(1):1-10. PubMed ID: 9356287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.